As we know, the tumor cells send out signals to the surrounding area, seeking a blood supply and a foundation upon which to spread.Scientists present a finding - published in the journal Cancer Research- that an antibody against the protein EphA3 has antitumor effects, providing a new approach to treat solid tumors. The antibody damaged tumor blood vessels and disrupted the stromal micro-environment, and cancer cells died because their 'life-support' was compromised. The microenvironment is so important for tumor cell survival that monoclonal antibodies against EphA3 can act as one way to kill a variety of solid tumors by disrupting their microenvironment. Tumor cells, without EphA3 in itself, can thrive by recruiting and taking advantage of supporting EphA3-containing cells in the tumor microenvironment. A novel research highlights that highly specialized immune cells, called natural killer cells, play critical important role in killing melanoma cells that have spread to the lungs. In the experiment where human prostate cancer cells were introduced into a mouse model, researchers found EphA3 in stromal cells and blood vessels surrounding the tumor. Currently, KaloBios Pharmaceuticals is testing the anti-EphA3 antibody Kb004 in a multi-centre Phase I/II clinical trial in Melbourne and the US in patients with EphA3-expressing blood malignancies: AML, MDS and myelofibrosis. And EphA3-expressing stromal stem cells, once receiving signals, can form cells that support and create blood vessels in tumors. As reported, these natural killer cells could be Pest Trap Manufacturers harnessed to hunt down and kill cancers that have spread in the body. Also, they observed the treatment with an antibody against EphA3 (chIIIA4) significantly slowed tumor growth. A novel research highlights that highly specialized immune cells, called natural killer cells, play critical important role in killing melanoma cells that have spread to the lungs. As EphA3 is present in normal organs only during embryonic development but is expressed in solid tumors, this antibody-based approach may be a suitable candidate treatment for solid tumors. As reported, these natural killer cells could be harnessed to hunt down and kill cancers that have spread in the body.
